Thermo Fisher CDR (Cad Hedged) (TMO.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 1,688,200 | 1,684,800 | 999,900 | 983,700 | 863,500 |
| Income taxes - deferred | -524,800 | -621,800 | -472,800 | -301,600 | -123,100 |
| Accounts receivable | -149,400 | -145,400 | -147,900 | 12,000 | -107,300 |
| Accounts payable and accrued liabilities | -2,700 | 1,200 | 47,000 | 10,000 | 31,400 |
| Other Working Capital | -399,400 | 217,500 | 158,900 | -11,000 | -264,900 |
| Other Operating Activity | 2,205,000 | 1,483,300 | 1,425,600 | 1,346,400 | 1,291,400 |
| Operating Cash Flow | $2,816,900 | $2,619,600 | $2,010,700 | $2,039,500 | $1,691,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -404,800 | -378,300 | -261,700 | -302,300 | -258,300 |
| Net Acquisitions | -694,600 | -11,538,300 | -11,400 | -1,083,400 | -5,684,800 |
| Sale Of Investment | 12,000 | 88,600 | 7,600 | 1,900 | 47,100 |
| Other Investing Activity | 0 | 45,300 | 2,200 | 58,000 | 753,800 |
| Investing Cash Flow | $-1,087,400 | $-11,782,700 | $-263,300 | $-1,325,800 | $-5,142,200 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 49,500 | -286,500 | 187,900 | -825,300 | 908,500 |
| Debt Issued | 1,798,000 | 6,592,300 | 3,167,800 | 1,282,100 | 4,254,100 |
| Debt Repayment | -3,780,200 | -4,429,400 | -1,000 | -354,500 | -453,400 |
| Common Stock Issued | 0 | 2,942,000 | 230,400 | 254,100 | 158,100 |
| Common Stock Repurchased | -500,000 | 0 | -89,800 | -1,150,000 | -1,337,500 |
| Dividend Paid | -240,600 | -234,800 | -216,200 | -142,200 | N/A |
| Other Financing Activity | 182,000 | 212,500 | 30,900 | 18,100 | 20,800 |
| Financing Cash Flow | $-2,491,300 | $4,796,100 | $3,310,000 | $-917,700 | $3,550,600 |
| Exchange Rate Effect | -129,600 | -115,500 | -37,000 | 38,700 | -200 |
| Beginning Cash Position | 1,343,500 | 5,826,000 | 805,600 | 1,016,300 | 917,100 |
| End Cash Position | 452,100 | 1,343,500 | 5,826,000 | 851,000 | 1,016,300 |
| Net Cash Flow | $-761,800 | $-4,367,000 | $5,057,400 | $-204,000 | $99,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,816,900 | 2,619,600 | 2,010,700 | 2,039,500 | 1,691,000 |
| Capital Expenditure | -422,900 | -427,600 | -282,400 | -315,100 | -266,500 |
| Free Cash Flow | 2,394,000 | 2,192,000 | 1,728,300 | 1,724,400 | 1,424,500 |